Bitterroot Bio
Palo Alto
About Bitterroot Bio
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $145.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2023)
- Website: brbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Emergency Medicine, Medical
Social Profiles
Canonical: https://fsome.com/organization/bitterroot-bio-65283 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.